MC
TLSI icon

Meteora Capital’s TriSalus Life Sciences TLSI Stock Holding History

Meteora Capital’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-34,554
Closed -$362K – 386
2023
Q2 		$362K Buy
34,554
+10,491
+44% +$109K 0.07% 174
2023
Q1 		$246K Hold
24,063
– – 0.03% 218
2022
Q4 		$241K Sell
24,063
-27,335
-53% -$274K 0.05% 163
2022
Q3 		$510K Hold
51,398
– – 0.13% 135
2022
Q2 		$506K Buy
+51,398
New +$505K 0.1% 165

Other funds holding TLSI

CWM
Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return
AC
Anson Capital Tyrone, Georgia $154M AUM 17.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GWSG
GPS Wealth Strategies Group Centennial, Colorado $117M AUM 24.22% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Meteora Capital's TLSI Position: Q3 2023 in Review

Meteora Capital sold out of TriSalus Life Sciences (TLSI) in Q3 2023, closing a stake of 34,554 shares — an estimated $362K sold.

Meteora Capital first reported a position in TLSI in Q2 2022 and held it in 5 quarters. The position peaked at $510K in Q3 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q3 2023.

  • Meteora Capital reported no remaining TriSalus Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Meteora Capital sold 34,554 TriSalus Life Sciences shares in Q3 2023, an estimated $362K.
  • Meteora Capital first reported a position in TriSalus Life Sciences in Q2 2022 and held it in 5 quarters.
  • Meteora Capital's TriSalus Life Sciences position peaked at $510K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2023.

Based on Meteora Capital's 13F filing for Q3 2023, filed 13 Nov 2023.